Prostatic enlargement - Causes, Treatment & When to See a Doctor

What is Prostatic Enlargement?

Prostatic enlargement, medically termed **benign prostatic hyperplasia (BPH)**, is a non‑cancerous increase in the size of the prostate gland. The prostate sits just below the bladder and surrounds the urethra, which carries urine out of the body. As the gland grows, it can compress the urethra and interfere with normal urinary flow. BPH is extremely common in men over the age of 50, affecting up to 50 % of men by age 60 and 80 % by age 80.¹ Although “benign” means it is not cancerous, the symptom burden can be significant and can affect quality of life.

Common Causes

While the exact trigger for BPH is not fully understood, several factors are known to contribute to prostate growth. Below are the most frequently cited causes or risk factors:

• Age – Hormonal changes with aging, especially a shift in the testosterone‑to‑estradiol ratio, promote tissue proliferation.
• Androgen Activity – Dihydrotestosterone (DHT), a metabolite of testosterone, stimulates prostate cell growth.
• Family History – Men with a first‑degree relative (father, brother) who has BPH are at higher risk.
• Obesity – Excess adipose tissue increases inflammatory cytokines and alters hormone metabolism.
• Metabolic Syndrome – Diabetes, high blood pressure, and dyslipidemia have been linked to larger prostate volume.²
• Dietary Factors – High intake of red meat and saturated fat and low consumption of fruits/vegetables may accelerate growth.
• Physical Inactivity – Sedentary lifestyle is associated with higher BPH prevalence.
• Medications – Certain drugs (e.g., antihistamines, decongestants, some antidepressants) can worsen urinary symptoms by affecting bladder muscle tone.
• Chronic Inflammation – Repeated urinary tract infections or prostatitis may stimulate hyperplasia.
• Hormone‑Modulating Conditions – Conditions that affect estrogen or testosterone levels (e.g., pituitary disorders) can influence prostate size.

Associated Symptoms

Many men with an enlarged prostate experience lower urinary tract symptoms (LUTS). The severity can range from mild inconvenience to disabling obstruction.

• Frequent urination, especially at night (nocturia)
• Urgency – a sudden, compelling need to void
• Weak or intermittent urinary stream
• Difficulty starting urination (hesitancy)
• Feeling of incomplete bladder emptying
• Dribbling after completion of voiding
• Post‑void residual urine (retained urine after voiding)
• Occasional urinary tract infections caused by residual urine

In some cases, enlarged prostate can cause complications such as bladder stones, kidney damage, or urinary retention, underscoring the importance of timely evaluation.

When to See a Doctor

Most men with mild symptoms can be monitored, but certain warning signs merit prompt medical attention:

• Sudden inability to urinate (acute urinary retention)
• Persistent pain or burning during urination
• Blood in the urine (hematuria) or semen
• Fever, chills, or flank pain – possible kidney infection
• Severe nocturia (more than twice per night) that disrupts sleep
• Symptoms that progressively worsen or interfere with daily activities

If any of these occur, contact a primary‑care physician, urologist, or go to the emergency department.

Diagnosis

Evaluating prostatic enlargement involves a combination of history, physical exam, and targeted tests.

1. Medical History & Symptom Scores

Doctors often use validated questionnaires such as the International Prostate Symptom Score (IPSS) to quantify severity and monitor response to treatment.

2. Digital Rectal Examination (DRE)

During a DRE, the clinician feels the prostate through the rectal wall to assess size, consistency, and the presence of nodules that might suggest cancer.

3. Urinalysis

A simple urine dipstick helps rule out infection, blood, or glucose that could mimic or exacerbate symptoms.

4. Prostate‑Specific Antigen (PSA) Test

While PSA is primarily a cancer screening tool, elevated levels can also be seen with BPH or prostatitis. PSA results often guide the need for further imaging.

5. Bladder Scan or Ultrasound

Non‑invasive bladder ultrasound estimates post‑void residual volume and can visualize prostate size.

6. Uroflowmetry

A device measures the speed and volume of urine flow, helping quantify obstruction.

7. Cystoscopy or Imaging (CT/MRI)

In complex cases, direct visualization of the urethra or advanced imaging may be ordered to assess for bladder stones, tumors, or ureteral involvement.

Treatment Options

Management is individualized based on symptom severity, prostate size, comorbidities, and patient preference. Options fall into three broad categories: lifestyle modifications, medications, and surgical/interventional therapies.

1. Lifestyle & Home Measures

• Fluid Management: Reduce evening fluid intake and limit caffeine/alcohol, which irritate the bladder.
• Timed Voiding: Schedule bathroom trips every 2–4 hours to avoid bladder over‑distension.
• Pelvic Floor Exercises: Strengthening the bulbocavernosus muscle may improve urinary control.
• Weight Control & Exercise: Regular aerobic activity (150 min/week) lowers inflammation and may reduce prostate growth.

2. Medications

• α‑Blockers (e.g., tamsulosin, alfuzosin): Relax smooth muscle in the prostate and bladder neck, improving flow within days.
• 5‑α‑Reductase Inhibitors (e.g., finasteride, dutasteride): Block conversion of testosterone to DHT, shrinking the gland over 6–12 months.
• Combination Therapy: Using an α‑blocker plus a 5‑α‑reductase inhibitor is effective for men with larger prostates and moderate‑to‑severe symptoms.
• Phosphodiesterase‑5 Inhibitors (e.g., tadalafil): May relieve LUTS while treating erectile dysfunction.
• Anticholinergics or β‑3 Agonists (e.g., mirabegron): Useful when overactive bladder symptoms predominate, but caution is needed if significant urinary retention exists.

All medications have potential side effects; discuss risks such as dizziness (α‑blockers) or sexual dysfunction (5‑α‑reductase inhibitors) with your provider.

3. Minimally Invasive Procedures

• Transurethral Resection of the Prostate (TURP): Gold‑standard surgical removal of prostate tissue; effective for moderate‑to‑severe obstruction.
• Transurethral Incision of the Prostate (TUIP): Small incisions relieve pressure; suited for smaller prostates.
• Laser Therapies (HoLEP, GreenLight): Vaporize or enucleate tissue with less bleeding and quicker recovery.
• UroLift® (prostatic urethral lift): Implants hold open the urethra without cutting tissue; preserves sexual function.
• Prostatic Artery Embolization (PAE): Interventional radiology technique that reduces blood flow to the gland, shrinking it over time.

4. Open or Robot‑Assisted Prostatectomy

Reserved for very large prostates (>80 mL) or when minimally invasive options are contraindicated.

Prevention Tips

While age‑related growth cannot be stopped entirely, several evidence‑based habits may slow progression or reduce symptom burden:

• Maintain a Healthy Weight: Aim for a BMI < 25 kg/m².
• Adopt a Plant‑Rich Diet: Foods high in lycopene (tomatoes), omega‑3 fatty acids (fish, flaxseed), and antioxidants have been associated with lower BPH risk.
• Stay Hydrated, But Time Fluids Wisely: Drink plenty of water during the day, but limit intake 2‑3 hours before bedtime.
• Limit Caffeine & Alcohol: Both can irritate the bladder and exacerbate nocturia.
• Exercise Regularly: Even moderate walking improves pelvic circulation.
• Screen for Diabetes & Hypertension: Treating metabolic conditions reduces inflammatory drivers of prostate growth.
• Avoid Chronic Catheter Use: Reduces risk of infection and inflammation.
• Discuss Medications: If you take drugs that worsen urinary symptoms, ask your doctor about alternatives.

Emergency Warning Signs

---

**References**

1. Mayo Clinic. Benign prostatic hyperplasia (BPH). https://www.mayoclinic.org. Accessed May 2026.
2. NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Prostatic Hyperplasia and Metabolic Syndrome.” https://www.niddk.nih.gov. 2023.
3. Cleveland Clinic. Benign Prostatic Hyperplasia (BPH) Treatment Options. https://my.clevelandclinic.org. Accessed May 2026.
4. World Health Organization. “Guidelines on the Management of Lower Urinary Tract Symptoms in Men.” WHO Technical Report Series, 2022.
5. American Urological Association. Guideline for the Management of Benign Prostatic Hyperplasia, 2023. https://www.auanet.org.